임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
35건 표시
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis
리드: 셀트리온
- 3상모집 중단 (진행 중)· Non Squamous Non Small Cell Lung CancerA Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
리드: 셀트리온
- 3상완료· Moderately to Severely Active Rheumatoid ArthritisA Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis
리드: 셀트리온
- 3상상태 미확인· Inflammatory Bowel DiseasesPharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
협력: 셀트리온
- 3상모집 중· Relapsing-remitting Multiple SclerosisA Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
리드: 셀트리온
- 3상초청 등록· Non-Alcoholic Fatty Liver DiseaseClinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
협력: 셀트리온
- 3상상태 미확인· Rheumatoid ArthritisA Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· Moderate to Severe Chronic Plaque PsoriasisTo Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisA Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
리드: 셀트리온
- 3상모집 중· Inflammatory DiseaseInDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
협력: 셀트리온
- 3상완료· Diabetic Macular Edema (DME)Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
리드: 셀트리온
- 3상완료· Postmenopausal Women With OsteoporosisA Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
리드: 셀트리온
- 3상완료· Chronic Spontaneous UrticariaTo Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisA Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisA Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisA Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA
리드: 셀트리온
- 3상완료· Follicular LymphomaTo Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisPK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis
리드: 셀트리온
- 3상완료· Lymphoma, FollicularTo Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan
리드: 셀트리온
- 3상완료· HER2-positive Carcinoma of BreastEfficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisProgram evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
리드: 셀트리온
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.